US Patent:
20100285979, Nov 11, 2010
Inventors:
Martha Allen Zeiger - Bethesda MD, US
Nijaguna B. Prasad - Columbia MD, US
Steven K. Libutti - Potomac MD, US
Christopher B. Umbricht - Towson MD, US
International Classification:
C40B 30/02
C12Q 1/68
C40B 30/00
US Classification:
506 8, 435 6, 506 7, 506 13, 506 14
Abstract:
The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.